Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
pentobarbitalnatrium 390 mg/phenytoinnatrium 50 mg injektionsvæske, opløsning, hætteglas |
Is a |
Product containing phenytoin in parenteral dose form (medicinal product form) |
false |
Inferred relationship |
Some |
|
|
pentobarbitalnatrium 390 mg/phenytoinnatrium 50 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Phenytoin - chemical |
false |
Inferred relationship |
Some |
|
|
pentobarbitalnatrium 390 mg/phenytoinnatrium 50 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Phenytoin (substance) |
false |
Inferred relationship |
Some |
|
|
pentobarbitalnatrium 390 mg/phenytoinnatrium 50 mg injektionsvæske, opløsning, hætteglas |
Is a |
pentobarbitalnatrium + phenytoinnatrium |
false |
Inferred relationship |
Some |
|
|
pentobarbitalnatrium 390 mg/phenytoinnatrium 50 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Pentobarbital sodium |
false |
Inferred relationship |
Some |
|
|
pentobarbitalnatrium 390 mg/phenytoinnatrium 50 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Phenytoin sodium (substance) |
false |
Inferred relationship |
Some |
|
|
pentobarbitalnatrium 390 mg/phenytoinnatrium 50 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Barbiturate sedative (substance) |
false |
Inferred relationship |
Some |
|
|
pentobarbitalnatrium 390 mg/phenytoinnatrium 50 mg injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
injektionsvæske |
false |
Inferred relationship |
Some |
|
|
pentobarbitalnatrium 390 mg/phenytoinnatrium 50 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Sedative (substance) |
false |
Inferred relationship |
Some |
|
|